Reprint

Drug Metabolism, Pharmacokinetics and Bioanalysis

Edited by
June 2019
230 pages
  • ISBN978-3-03897-916-6 (Paperback)
  • ISBN978-3-03897-917-3 (PDF)

This book is a reprint of the Special Issue Drug Metabolism, Pharmacokinetics and Bioanalysis that was published in

Biology & Life Sciences
Chemistry & Materials Science
Medicine & Pharmacology
Summary

Drug metabolism/pharmacokinetics and drug interaction studies have been extensively carried out in order to secure the druggability and safety of new chemical entities throughout the development of new drugs. Recently, drug metabolism and transport by phase II drug metabolizing enzymes and drug transporters, respectively, as well as phase I drug metabolizing enzymes, have been studied. A combination of biochemical advances in the function and regulation of drug metabolizing enzymes and automated analytical technologies are revolutionizing drug metabolism research. There are also potential drug–drug interactions with co-administered drugs due to inhibition and/or induction of drug metabolic enzymes and drug transporters. In addition, drug interaction studies have been actively performed to develop substrate cocktails that do not interfere with each other and a simultaneous analytical method of substrate drugs and their metabolites using a tandem mass spectrometer. This Special Issue has the aim of highlighting current progress in drug metabolism/pharmacokinetics, drug interactions, and bioanalysis.

Format
  • Paperback
License
© 2019 by the authors; CC BY-NC-ND license
Keywords
procainamide; N-acetylprocainamide; ultra-high-pressure liquid chromatography; rat; plasma; pharmacokinetics; adalimumab; immunoprecipitation; liquid chromatography-quadrupole TOF MS; bioanalysis; GB3; Fabry disease; LC-QTOF-MS/MS; B6;129-Glatm1Kul/J; cytochrome P450; drug interaction; liquid chromatography-tandem mass spectrometry; organic anion transporting polypeptide; pharmacokinetics; Korean red ginseng extract; metformin; diabetes; drug interaction; pharmacokinetics; efficacy; ethyl glucuronide; hair; HPLC-MS/MS; AUDIT score; alcohol addiction; eurycomanone; Eurycoma longifolia; bioavailability; pharmacokinetic; anthraquinone; glycoside; aglycone; LC-MS/MS; plasma; protein precipitation; loxoprofen; CYP; UGT; human liver microsomes; LC-HR/MS; mematine; drug interaction; liquid chromatography-tandem mass spectrometry; pharmacokinetics; biopharmaceuticals; drying technology; protein stability; bioavailability; pharmacokinetics; DA-9805; saikosaponin a; paeonol; imperatorin; pharmacokinetics; brain distribution; Osthenol; CYP; UGT; human liver microsomes; glucuronidation; Stauntonia hexaphylla leaf extract; YRA-1909; pharmacokinetics; chlorogenic acid; neochlorogenic acid; cryptochlorogenic acid; caffeic acid; caffeic acid O-glucuronides; LC-MS/MS; aceclofenac; diclofenac; esomeprazole; pharmacokinetics; gastric ulcer; acetyl tributyl citrate; pharmaceutical excipient; pharmacokinetics; metabolic stability; plasma